Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical trial of different dosing intervals of injectable civapetide in HIV-1 infection
CTR20150281Phase 2Active
- Sponsor
- Tianjin Fusogen Pharmaceuticals
- Start
- Apr 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of sifuvirtide in human immunodeficiency virus infection (HIV), acquired immunodeficiency syndrome (AIDS), sponsored by Tianjin Fusogen Pharmaceuticals. Started Apr 2015; status: active.
02
Drugs
sifuvirtide
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on CTR20150281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150281.